Bayerisch Gmain, Germany

Oliver Buck



 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2009-2019

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Oliver Buck - Innovator in Radionuclide Therapy

Introduction

Oliver Buck, an inventive mind hailing from Bayerisch Gmain, Germany, is recognized for his significant contributions in the field of medical technology with 6 granted patents. His focus on radionuclide therapy has led to innovations designed to improve treatment outcomes for patients suffering from skin cancers.

Latest Patents

Among his latest innovations is the "Layer Structure for Epidermal Radionuclide Therapy." This invention discloses a specialized layer structure for brachytherapy treatment, consisting of a proximal adherent layer designed for skin application, followed by a flexible, transparent carrier layer. The configuration allows for effective delivery of radionuclides while ensuring transparency to beta and gamma radiation, making it particularly suitable for treating complex skin lesions such as basal-cell carcinoma (BCC) and squamous cell carcinoma (SCC). Another notable patent is the "Applicator for Applying a Radioactive Substance to Biological Tissue." This applicator includes a container for radioactive substances and a connecting application device that facilitates targeted delivery to biological tissues, enhancing treatment precision.

Career Highlights

Oliver Buck has made a significant impact in his field through positions at leading organizations like Isotopen Technologien München AG and Oncobeta International GmbH. His work at these companies has been pivotal in advancing radionuclide therapy technologies, demonstrating his commitment to improving patient care through innovative solutions.

Collaborations

Throughout his career, Oliver has collaborated with esteemed colleagues such as Michael Schilp and Tuomo Nikula. These partnerships have fostered an environment of shared expertise and creativity, further propelling the advancements in medical technology and therapeutic applications.

Conclusion

As an inventor, Oliver Buck stands out for his groundbreaking innovations in radionuclide therapy. His patents not only showcase his technical expertise but also reflect his dedication to developing effective treatments for patients battling skin cancer. Through his work, Buck continues to contribute to the advancement of medical technology, offering hope and improved outcomes for those in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…